New stock news | China Medical Technology submits application to Hong Kong Stock Exchange
According to the prospectus, the National Medical Technology is the leader in China's third-party SPD solution market.
According to the disclosure on Hong Kong Stock Exchange on January 21, Anhui Zhongxi Guoyi Medical Technology Co., Ltd. (referred to as "Guoyi Technology") has submitted an application for listing on the main board of the Hong Kong Stock Exchange, with Haitong International Capital Limited as its exclusive sponsor. According to the prospectus, Guoyi Technology is the leader in China's third-party SPD solution market. According to Frost & Sullivan report, based on the revenue in 2024, Guoyi Technology is the largest third-party SPD solution provider in China, with a market share of 29.2%. According to the same report, the company is also the first third-party SPD solution provider in China.
Related Articles

New stock news: Puqi Pharmaceuticals has submitted an application to the Hong Kong Stock Exchange. Its core product, the PMX-809 gel, has completed phase III clinical trials.

EB SECURITIES: Price Approval Guidelines Released Focus on Domestic Surgery Siasun Robot&Automation Commercialization Promotion

New stock news | China Medical Technology submits application to Hong Kong Stock Exchange, becoming the largest third-party SPD solution provider in China.
New stock news: Puqi Pharmaceuticals has submitted an application to the Hong Kong Stock Exchange. Its core product, the PMX-809 gel, has completed phase III clinical trials.

EB SECURITIES: Price Approval Guidelines Released Focus on Domestic Surgery Siasun Robot&Automation Commercialization Promotion

New stock news | China Medical Technology submits application to Hong Kong Stock Exchange, becoming the largest third-party SPD solution provider in China.

RECOMMEND

Moving Toward “7*24 Hour” Trading! NYSE Seeks Approval For “All‑Weather Blockchain Trading Platform”
21/01/2026

China Internet 2026: Under Pressure From ByteDance, Major Players Launch Full‑Scale Contest For AI Entry Points
21/01/2026

Hong Kong Equity Refinancing Opens Strong In 2026, Raising Over HKD 27 Billion
21/01/2026


